Article Under Review
This article is undergoing editorial and medical review. We regularly update content as part of our commitment to providing patient-centered, accurate, evidence-based information.
Overview
Your relationship with your team does not end after collection. You will have visits, blood work, and checkups over months and years. This check-in helps keep you safe and adds to research showing that giving cells is safe.
Visits are usually simple. You might have in-person meet-ups at set times (one week, one month, six months, one year) plus yearly visits after that. Your team may also send health forms. These check-ups help spot any rare late problems early. Studies show stem cell giving does not raise cancer risk, hurt bone, or affect having babies.
Why follow-up matters
Long-term follow-up protects you by identifying any delayed complications early. It also benefits future donors by contributing to the research showing donation safety. Every donor's outcome data helps transplant centers and regulatory agencies understand the long-term effects of donation and improve processes.
Your participation in follow-up also helps the transplant field. Donor registries track outcomes from thousands of donors. This data proves whether PBSC donation increases cancer risk, whether bone marrow donation causes long-term bone problems, and whether donation affects fertility or pregnancy outcomes. Research based on donor follow-up data has repeatedly shown donation is safe.
For family donors, follow-up monitoring is important if any issues arise with the recipient. If the recipient experiences complications, knowing about the donor's health status helps medical teams troubleshoot problems. For all donors, follow-up is part of supporting the transplant process long-term.
- Follow-up tracks your long-term health
- Identifies rare delayed complications
- Contributes to donation safety research
- Helps inform future donor counseling
- Usually straightforward and non-invasive
Your follow-up schedule
Standard follow-up timeline
Follow-up timing varies, but typical schedules include:
- 1 week post-collection: phone call or in-person visit checking on recovery
- 4 weeks post-collection: follow-up blood work assessing blood counts
- 3 months post-collection: assessment of pain, wound healing, overall recovery
- 6 months post-collection: more detailed visit or phone assessment
- 1 year post-collection: comprehensive follow-up visit
- 5 years post-collection: additional follow-up visit
- 10 years post-collection: long-term assessment
After 10 years, most follow-up is completed, though you're encouraged to report any new health issues to your coordination center. Some donors participate in long-term registries even beyond 10 years, contributing to ongoing research.
Individualized monitoring adjustments
Your specific schedule depends on your center, your health, and any complications. If you had an uncomplicated recovery, follow-up visits might be briefer or done by phone. If you had any issues, closer monitoring might continue longer.
- 1-week post-collection check-in
- 4-week, 3-month, 6-month follow-ups
- Annual visit at 1 year
- Additional visits at 5 and 10 years
- Individual variation in schedule
What tests or check-ins to expect
Standard follow-up assessments
Follow-up blood tests check your complete blood count (ensuring your blood cells recovered to normal), liver function, kidney function, and other parameters. These tests track that your bone marrow fully recovered and that no organ damage occurred.
Tests typically include:
- Complete blood count assessing recovery of red cells, white cells, and platelets
- Liver and kidney function tests
- Metabolic panel checking electrolytes
- Cardiac exam assessing your heart health
- Spleen ultrasound (PBSC donors) confirming return to normal size
- Wound assessment (bone marrow donors) for healing and pain
Physical exams assess your overall health, including vital signs, cardiac exam, lung exam, abdominal exam, and assessment of donation-related sites. Your doctor asks about new medical conditions and medications.
Reproductive and cancer screening
You might be asked about pregnancy outcomes, fertility concerns, and new health diagnoses. You're asked about cancer screening participation (colonoscopy, mammograms, etc.) and whether you've had any new cancer diagnoses.
- Complete blood count
- Liver, kidney, metabolic function
- Cardiac exam and assessment
- Spleen ultrasound (PBSC donors)
- Wound assessment (bone marrow donors)
Reporting to NMDP and CIBMTR
Your coordination center collects data on your follow-up visits and reports it to the NMDP and CIBMTR (Center for International Blood and Marrow Transplant Research). This data is anonymized—your name isn't shared—but your outcome information is used for research and safety monitoring.
You might be contacted directly by researchers asking about your health. These contacts are usually brief phone calls or email surveys asking about new diagnoses, surgeries, pregnancy outcomes, or other major health events. Participating in these surveys is voluntary but encouraged—your responses directly support research on donor safety.
NMDP reporting is particularly important for tracking serious adverse events (severe complications, cancers, deaths). If you develop a serious condition, your center reports this to the NMDP. This doesn't mean you did anything wrong; it means the transplant system is monitoring whether donation caused the condition or whether it's coincidental.
- Coordination center reports your data to NMDP and CIBMTR
- Data is anonymized for research
- You might be contacted for follow-up surveys
- Serious events are reported
- Your data protects future donors
Your long-term health
Most donors experience no long-term effects from donation. Your bones are unchanged by the donation process. Your blood cells return to normal levels. Your cancer risk is not increased by donation (this has been shown in multiple large studies). Your fertility and pregnancy outcomes are normal.
You should maintain routine health screening appropriate for your age and risk factors. Get cancer screenings (mammograms, colonoscopies, etc.) on schedule. Maintain health behaviors (not smoking, managing weight, regular exercise). These general health practices matter more than anything specific to donation.
If you develop a new health problem years after donation, report it to your coordination center. They'll want to know. It probably isn't related to donation, but they track all serious events. Be honest about your health—this allows the system to continuously improve safety monitoring.
You're no longer "a donor" after follow-up is complete. You're just you, living your life. But the transplant community appreciates your participation in follow-up and research.
- Long-term effects very rare
- Blood counts return to normal
- Cancer risk not increased
- Fertility/pregnancy unaffected
- Maintain routine health screening
Additional Detailed Information
Additional Information
Follow-up protocol details
FACT-AABB guidelines. International standards require donation centers to contact donors at specific intervals: 1 week, 4 weeks, 3 months, 6 months, 1 year, 5 years, and 10 years post-donation. Some centers exceed these minimum standards with additional contact. Donors who can't be reached at recommended intervals are still considered to have had adequate follow-up.
Data collection forms. Follow-up visits involve standardized questionnaires and data collection. Donors are asked about intervening medical events, cancer diagnoses, fertility outcomes, medication use, and occupation changes. This standardized data collection across centers allows research comparisons.
NMDP and CIBMTR reporting systems
Donor outcome registry. The NMDP maintains a national registry of all donors and their outcomes. Registry data is linked to transplant outcomes, allowing researchers to correlate donor and recipient characteristics with transplant success. Data is reported for research and adverse event tracking.
Serious adverse event (SAE) reporting. Serious adverse events (malignancy, severe infections, deaths, major organ failure) are reported to regulatory agencies. These reports trigger investigation to determine if the event is likely related to donation or coincidental. SAE reporting identifies any signals of unexpected adverse effects.
Long-term research outcomes
PBSC donor studies. Studies following PBSC donors for 15-20 years show no increased cancer incidence compared to the general population. Cardiac outcomes are normal. No increased mortality. Fertility and pregnancy outcomes are normal. These studies provide strong evidence that PBSC donation is safe long-term.
Bone marrow donor studies. Studies of bone marrow donors followed 10-20+ years show similar safety profiles. Bone integrity is maintained (no osteoporosis). No increased cancer incidence. Fertility and pregnancy outcomes are normal. Chronic pain occurs in <5% of donors and usually resolves.
Written By:
Transplants.org Staff
Last Reviewed: February 26, 2026
Informed By:
Transplants.org, with participation from 23 leading U.S. transplant centers, led the largest comparative analysis of patient educational materials in transplant history. We recognize the participating centers who helped inform and inspire our direction with initial patient-centered educational content:
- Mayo Clinic (Co-Author)
- Vanderbilt University Medical Center (Co-Author)
- Johns Hopkins Hospital (Co-Author)
- UCLA Medical Center (Co-Author)
- UCSF Medical Center (Co-Author)
Transplants.org is an independent nonprofit organization and participation is not an endorsement by these organizations.
